Single Arm Phase II Study of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) in Older Patients Using Fludarabine and Total Body Irradiation (FluTBI) Regimen
Status: Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Fludarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms FluTBI
- 13 Sep 2019 Planned End Date changed from 1 Jun 2019 to 1 Jul 2021.
- 13 Sep 2019 Planned primary completion date changed from 1 Jun 2019 to 28 Feb 2021.
- 04 Jun 2019 Trial design presented at 55th Annual Meeting of the American Society of Clinical Oncology